IQVIA
Search results
For over 35 years Parexel has been a trusted global CRO and biopharmaceutical services company. Learn more about how we can help.
Transform healthcare, trial new treatments, and reinvent medicine to change patients’ lives – and do it With Heart. Explore careers with Parexel today.
Parexel is among the world’s largest clinical research organizations, providing the full range of Phase I to IV clinical development services. Learn more. Solutions
The company publishes the annual Parexel R&D Statistical Sourcebook [4] and operates the Parexel-Academy. [5] Parexel was founded in 1982 by Josef von Rickenbach [6] and organic chemist Anne B. Sayigh [7] initially to advise Japanese and German firms on how to navigate the FDA approval process. [8]
Parexel's CRO solutions offer a variety of opportunities from consulting to integrated research. Learn more about our CRO services.
Parexel is among the world’s largest clinical research organizations (CROs), providing the full range of Phase I to IV clinical development services to help life-saving treatments reach patients...
Whatever the size of your biopharmaceutical company, our global presence can help accelerate your drug development around the world. Our diverse professionals represent the best and the brightest in clinical, regulatory and market access specialties.
At Parexel, we’ve integrated our wide range of services across all our business units, giving us speed & flexibility. Learn about our biotech clinical trial solutions.
At Parexel, we combine a comprehensive portfolio of medical communications services with expertise in all major therapeutic areas, as well as clinical development, patient engagement, real-world evidence, health economics, market access, regulatory, and more — to communicate vital data to your stakeholders.
Headquartered near Boston, Massachusetts and in Durham, North Carolina, Parexel has over 16,000 employees, with offices that support clients in over 100 countries around the world. We provide the most comprehensive drug development capabilities of any CRO worldwide.
